Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Consumer Discretionary · ·
$94.51
▼ $1.49 (-1.6%)
Market data updated: 09/18 08:26 AM
Fundamentals updated: 09/17/2026
News analyzed: 09/18/2026
Market Cap
$7.82B
Day Range
$93.70 - $96.23
52-Week Range
$72.76 - $107.62
Beta
—
Next Earnings
01.12.2026
HQY is a stock from the Consumer Cyclical sector — Retail, automotive, and leisure — demand rises and falls with economic sentiment and consumers' disposable income.
+2.7% (1Y)
Strengths: 15/31 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Earnings per share (EPS) growth
Earnings per share (EPS) growth: 125.7%
Growth
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.33 (3y annualized return 11.9% / max drawdown 36.1%)
Risk
Signal tension
Growth scores strong (76/100), but fair-value analysis scores this stock as relatively expensive (45/100) — the growth story and the current price aren't fully aligned.
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 3 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 3
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
62
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
76
Quality
63
Value
45
Momentum
38
Risk
54
Sentiment
98
Fundamental
78
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of HealthEquity, Inc. has centered on its strong financial performance and growth in health savings accounts (HSAs), with a 15.7% stock rally over three months driven by rising HSA assets, improved margins, and higher revenue guidance. The company reported accelerated growth in Q2 2027, including an 8% year-over-year revenue increase and an 11% rise in adjusted EBITDA, signaling profitability and durability. Analysts, like Deutsche Bank, maintain a bullish outlook, raising price targets despite lingering concerns over cybersecurity risks.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about HealthEquity, Inc.. News trend score: 98. Reason: 11 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
15
🎯 Conviction (vs. Emotion)
43
Psychology
57
Fundamentals
78
Technical
38
Valuation
45
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+11%
Market Narrative
54
Fundamental Reality
43
Narrative Gap
+11
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior suggests **herding** is the dominant psychological state, driven by relative underperformance against peers (-1.8% vs. -1.1%). While extreme positive sentiment (98/100) and muted volatility (1.09x ATR) dampen panic or FOMO, the narrative gap (5-point discrepancy) hints at a disconnect between optimism and technical signals. The key question is whether traders are reacting to peer dynamics or awaiting a catalyst to realign sentiment with fundamentals. Overconfidence and loss aversion are absent, but the gap implies potential for rebalancing if momentum shifts.
Updated: 09/08/2026, 02:07 PM
What could change this?
👥 What the crowd believes
"HealthEquity's 15.7% three-month rally is backed by rising HSA scale"
"Adjusted EBITDA jumped 11% to $167 million"
"Deutsche Bank raises HealthEquity price target to $142"
"Sales and earnings beats in fiscal Q2 weren't enough to satisfy investors"
📈 3D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Walter Bagehot — 94/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 31/100
🗣️ Why do they disagree?
The stark contrast between Walter Bagehot’s near-perfect score (94) and Benjamin Graham’s lowest ratings (39 for Defensive, 31 for Enterprising) highlights a fundamental divide in how these methodologies evaluate stability versus value. Bagehot’s focus on liquidity and resilience during crises suggests HQY’s financial health could weather downturns, while Graham’s framework—rooted in deep discounts to intrinsic value—finds the stock neither cheap enough nor structurally sound enough for his risk-averse standards. Meanwhile, growth-oriented investors like Peter Lynch (86) and Samuel Nelson (80) see upside in the stock’s underpriced potential or cyclical positioning, contrasting sharply with Howard Marks’ caution (62) that the business may already be priced for perfection. The middle-ground approaches—from Fisher’s ‘solid but not exceptional’ (69) to Malkiel/Bogle’s ‘mixed case’ (57)—reflect a stock that’s neither a slam dunk nor a clear mispricing, leaving room for interpretation depending on whether one prioritizes defensive traits, growth momentum, or market efficiency.
Walter Bagehot
Lombard Street (1873)
🟢 94
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 86
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 75
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 72
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟢 69
Solid, but not the exceptional quality Fisher looked for
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 65
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 65
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 62
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 61
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 61
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 58
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 55
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 50
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 45
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 39
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 31
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Based on the last 281 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (3 bullish · 7 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
A trading range after an advance, but still without clear (volume-based) confirmation of a distribution phase.
Low confidence
$88.68
Range Bottom
$107.62
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
69.5%
Operating Margin
24.6%
Net Margin
16.4%
EBITDA Margin
36.3%
ROE
10.2%
ROA
6.4%
ROIC
—
EPS
$2.50
Cash
$318.93M
Total Debt
$957.38M
Current Ratio
3.27
Debt/Equity
0.45
How is Fair Value calculated? →
Current Price
$94.51
Estimated Fair Value (DCF)
$101.17
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+7.0%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
15.2%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 15.2% | $524.15M | $480.87M |
| 2 | 12.0% | $587.04M | $494.10M |
| 3 | 8.8% | $638.89M | $493.34M |
| 4 | 5.7% | $675.09M | $478.25M |
| 5 | 2.5% | $691.96M | $449.73M |
Base FCF (last actual year)
$455.13M
Terminal Value
$10.91B
Present Value of Terminal Value
$7.09B
Enterprise Value
$9.49B
Net Debt
$638.45M
Equity Value
$8.85B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$24.09
Tangible Book Value per Share (Tangible NAV)
-$7.30
Sentiment based on basic keywords (not AI) — 11 positive, 6 neutral, 3 negative out of the last 20 articles.
Zacks · 4.9.2026
Yahoo · 4.9.2026
Yahoo · 2.9.2026
Zacks · 2.9.2026
Yahoo · 1.9.2026
Insider Monkey · 1.9.2026
Yahoo · 1.9.2026
Motley Fool · 1.9.2026
Benzinga · 31.8.2026
MT Newswires · 31.8.2026
Yahoo · 30.8.2026
Motley Fool · 30.8.2026
Yahoo · 28.8.2026
Simply Wall St. · 28.8.2026
MT Newswires · 28.8.2026
Yahoo · 28.8.2026
Simply Wall St. · 28.8.2026
Benzinga · 28.8.2026
Yahoo · 27.8.2026
Yahoo · 27.8.2026
HealthEquity, Inc. (HQY) currently has a StockIQ AI score of 62/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
HQY currently scores 62/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, HQY's estimated fair value is $101.17, which is 7.0% above the current price of $94.51. This is one valuation model among several signals in the fair-value category, not a price target.
HQY's technical score is 38/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Earnings per share (EPS) growth: 125.7%; Free cash flow growth: 34.7%; Net income growth: 122.5%.
Based on the real signals StockIQ computed: Calmar: 0.33 (3y annualized return 11.9% / max drawdown 36.1%); Price is below the 50-day average; MACD histogram is negative — falling momentum.
StockIQ has no recorded dividend payment history for HQY.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 8 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| DILLON ADRIAN T | Exercise of Derivative Securities | 25.8.2026 | 70,027 | +7,632 | $32.50 |
| DILLON ADRIAN T | Open Market Sale | 25.8.2026 | 63,727 | -6,300 | $104.47 |
| DILLON ADRIAN T | Open Market Sale | 25.8.2026 | 62,395 | -1,332 | $105.26 |
| DILLON ADRIAN T | Exercise of Derivative Securities | 25.8.2026 | 0 | -7,632 | — |
| DILLON ADRIAN T | Open Market Sale | 25.8.2026 | 6,300 | -6,300 | $104.47 |
| DILLON ADRIAN T | Open Market Sale | 25.8.2026 | 1,332 | -1,332 | $105.26 |
| DILLON ADRIAN T | Exercise of Derivative Securities | 25.8.2026 | 7,632 | -7,632 | — |
| DILLON ADRIAN T | Exercise of Derivative Securities | 25.8.2026 | 7,632 | +7,632 | $32.50 |
| Fiore Michael Henry | Open Market Sale | 10.7.2026 | 2,354 | -2,354 | $95.00 |
| Fiore Michael Henry | Open Market Sale | 10.7.2026 | 52,244 | -2,354 | $95.00 |
| Gathright Michael | Tax Withholding in Shares | 9.7.2026 | 2,270 | -2,270 | $93.07 |
| Gathright Michael | Tax Withholding in Shares | 9.7.2026 | 39,893 | -2,270 | $93.07 |
| Fiore Michael Henry | Tax Withholding in Shares | 8.7.2026 | 2,045 | -2,045 | $95.08 |
| Cutler Scott | Tax Withholding in Shares | 8.7.2026 | 1,238 | -1,238 | $95.08 |
| Ladd Delano | Tax Withholding in Shares | 8.7.2026 | 1,087 | -1,087 | $95.08 |
| Lucania James M | Tax Withholding in Shares | 8.7.2026 | 2,839 | -2,839 | $95.08 |
| Neeleman Stephen | Tax Withholding in Shares | 8.7.2026 | 1,103 | -1,103 | $95.08 |
| Neeleman Stephen | Tax Withholding in Shares | 8.7.2026 | 137,565 | -1,103 | $95.08 |
| Lucania James M | Tax Withholding in Shares | 8.7.2026 | 104,617 | -2,839 | $95.08 |
| Ladd Delano | Tax Withholding in Shares | 8.7.2026 | 90,054 | -1,087 | $95.08 |
| Cutler Scott | Tax Withholding in Shares | 8.7.2026 | 176,405 | -1,238 | $95.08 |
| Fiore Michael Henry | Tax Withholding in Shares | 8.7.2026 | 54,598 | -2,045 | $95.08 |
| Fiore Michael Henry | Open Market Sale | 2.7.2026 | 2,470 | -2,470 | $95.00 |
| Fiore Michael Henry | Open Market Sale | 2.7.2026 | 56,643 | -2,470 | $95.00 |
| Natarajan Rajesh | Grant/Award from Employer | 25.6.2026 | 2,877 | +2,877 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
4,516,232 shares short as of 2026-08-31 · vs. 4,167,244 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
63.4% of trading volume this week was short selling, vs. 63.9% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology